Ellen Kurek

News
In Patients With Unfavorable Intermediate-Risk Prostate Cancer, Brachytherapy Improved Overall Survival Compared with External-Beam Radiotherapy
05/18/2022
Researchers reviewed the National Cancer Database records of nearly 32,000 men diagnosed with UIR prostate cancer to determine if men treated with brachytherapy had rates of survival comparable with those of men treated with EBRT.
Researchers reviewed the National Cancer Database records of nearly 32,000 men diagnosed with UIR prostate cancer to determine if men treated with brachytherapy had rates of survival comparable with those of men treated with EBRT.
Researchers reviewed the...
05/18/2022
Journal of Clinical Pathways
Conference Coverage
Efficacy of Teclistamab vs Real-World Treatments for Patients with Triple-Class Exposed, Relapsed/Refractory Multiple Myeloma
06/22/2022
A study presented at the 2022 ASCO Annual Meeting evaluated the comparative effectiveness of teclistamab vs treatment regimens using an external control arm from a real-world database, addressing the absence of a control arm in MajesTEC-1.
A study presented at the 2022 ASCO Annual Meeting evaluated the comparative effectiveness of teclistamab vs treatment regimens using an external control arm from a real-world database, addressing the absence of a control arm in MajesTEC-1.
A study presented at the 2022...
06/22/2022
Journal of Clinical Pathways
News
Quality Oncology Practice Initiative Finds Low Rates of Pre-Treatment Staging Imaging Among Patients With Rectal Cancer
05/25/2022
A recent study found that as many as half of patients with rectal cancer do not receive proper pre-treatment staging imaging, despite NCCN guideline recommendations for such imaging.
A recent study found that as many as half of patients with rectal cancer do not receive proper pre-treatment staging imaging, despite NCCN guideline recommendations for such imaging.
A recent study found that as...
05/25/2022
Journal of Clinical Pathways
News
Costs Among Patients With Endometrial Cancer Receiving Postoperative Hemoglobin Level Testing Following Robotic-assisted Hysterectomy
05/18/2022
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study suggest that postoperative hemoglobin testing may be safely avoided unless starting hemoglobin is
Findings from a recent study...
05/18/2022
Journal of Clinical Pathways
News
Cost and Outcomes of Cancer Surgery in Patients Eligible for Both Medicare and Medicaid in High-Quality Hospitals
04/27/2022
Findings from a recent study suggest that even among the highest-quality hospitals, dually eligible patients who receive cancer surgery may have poorer outcomes and higher spending.
Findings from a recent study suggest that even among the highest-quality hospitals, dually eligible patients who receive cancer surgery may have poorer outcomes and higher spending.
Findings from a recent study...
04/27/2022
Journal of Clinical Pathways
News
For Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer, Targeted Therapy Plus Endocrine Therapy Was Highly Ranked in Meta-Analysis
05/11/2022
Researchers conducted an information theoretic network meta-analysis to rank treatment regimens for hormone receptor-positive, ERBB2-negative metastatic breast cancer by their comparative effectiveness.
Researchers conducted an information theoretic network meta-analysis to rank treatment regimens for hormone receptor-positive, ERBB2-negative metastatic breast cancer by their comparative effectiveness.
Researchers conducted an...
05/11/2022
Journal of Clinical Pathways
News
Immune Checkpoint Inhibitors May Have Been Used Inappropriately in Half of Study Patients with Advanced Cancer Who Were Near the End of Life
05/18/2022
Immune checkpoint inhibitors (ICIs) have been shown to extend progression-free survival and overall survival in patients with a variety of cancers, leading to increases in the systemic treatment of patients with advanced cancer who are near...
Immune checkpoint inhibitors (ICIs) have been shown to extend progression-free survival and overall survival in patients with a variety of cancers, leading to increases in the systemic treatment of patients with advanced cancer who are near...
Immune checkpoint inhibitors...
05/18/2022
Journal of Clinical Pathways
News
Comparative Effectiveness of Ciltacabtagene Autoleucel vs Physician’s Choice of Therapy for Relapsed or Refractory Multiple Myeloma
05/16/2022
Ciltacabtagene autoleucel demonstrated superior efficacy to physician’s choice of therapy for patients with triple-class exposed, relapsed or refractory multiple myeloma in a recent study.
Ciltacabtagene autoleucel demonstrated superior efficacy to physician’s choice of therapy for patients with triple-class exposed, relapsed or refractory multiple myeloma in a recent study.
Ciltacabtagene autoleucel...
05/16/2022
Journal of Clinical Pathways
News
Progression-Free Survival Associated With Olaparib With or Without Cediranib vs Platinum-Based Chemotherapy in Women With High-Grade Ovarian Cancer
04/08/2022
Study findings suggest that neither olaparib monotherapy or olaparib plus cediranib increased progression-free survival when compared with platinum-based chemotherapy in women with high-grade serous or endometroid ovarian cancer sensitive to...
Study findings suggest that neither olaparib monotherapy or olaparib plus cediranib increased progression-free survival when compared with platinum-based chemotherapy in women with high-grade serous or endometroid ovarian cancer sensitive to...
Study findings suggest that...
04/08/2022
Journal of Clinical Pathways
News
Health Care Resource Utilization and Costs Associated With Disease Progression Among Patients With Metastatic Castration-Sensitive Prostate Cancer
06/09/2022
Study results show direct all-cause health care costs in patients with nmCSPC often rose several months prior to diagnosis with metastatic disease.
Study results show direct all-cause health care costs in patients with nmCSPC often rose several months prior to diagnosis with metastatic disease.
Study results show direct...
06/09/2022
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use